This webinar will summarize the Sunshine Act or Open Payments Program requirements and provide practical solutions to the most common situations that are prevalent and necessary between sponsors and investigators.
The Sunshine Act or Open Payments Program requires manufacturers of drugs, medical devices, and biologics that participate in U.S. federal health care programs to report certain clinical investigator payments and items of value given to physicians and teaching hospitals. This Act was part of a healthcare reform bill adopted in March 2010. It came about due to requests for increased transparency about the financial relationships between physicians and the industry.
WHY SHOULD YOU ATTEND?
The Sunshine Act exposes the physicians and sponsors to new clinical trial reporting requirements and detail non-compliance which would lead to hefty fines. Templates for reporting format, exemptions to reporting requirements, and timelines for compliance and enforcement will be discussed.
AREA COVERED
Life science companies face the challenge of implementing the detailed reporting required by the Act as healthcare providers determine how to use their own data to anticipate public reporting of payments by life science companies to physicians and teaching hospitals.
This webinar will examine the implications of the Sunshine Act for healthcare providers and life science companies and discuss practical steps they can take to implement the Act and prepare for transparency.
- Purpose of the Sunshine Act
- Who is required to report under the Sunshine Act?
- What is reported?
- Exclusions
- Tracking
- Penalties
- Useful links
WHO WILL BENEFIT?
- Manufacturers of FDA-regulated products: Drug, Medical Device, and Biotech Companies
- Clinical Trial Professionals such as Project Managers, CRAs, Medical Writers
- Senior Management for Companies developing new products for the US market
- Regulatory Affairs Professionals
- People investing in FDA-regulated products intended for the US market
The Sunshine Act exposes the physicians and sponsors to new clinical trial reporting requirements and detail non-compliance which would lead to hefty fines. Templates for reporting format, exemptions to reporting requirements, and timelines for compliance and enforcement will be discussed.
Life science companies face the challenge of implementing the detailed reporting required by the Act as healthcare providers determine how to use their own data to anticipate public reporting of payments by life science companies to physicians and teaching hospitals.
This webinar will examine the implications of the Sunshine Act for healthcare providers and life science companies and discuss practical steps they can take to implement the Act and prepare for transparency.
- Purpose of the Sunshine Act
- Who is required to report under the Sunshine Act?
- What is reported?
- Exclusions
- Tracking
- Penalties
- Useful links
- Manufacturers of FDA-regulated products: Drug, Medical Device, and Biotech Companies
- Clinical Trial Professionals such as Project Managers, CRAs, Medical Writers
- Senior Management for Companies developing new products for the US market
- Regulatory Affairs Professionals
- People investing in FDA-regulated products intended for the US market
Speaker Profile
Danielle DeLucy, MS, is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous filling and packaging operations. Danielle began her QA career as a Quality Control Pharmaceutical Microbiologist at a contract laboratory where she performed various tests for their clients. In the years after, she …
Upcoming Webinars
Outlook - Master your Mailbox - Inbox Hero Inbox Zero
So, You’re Now the “Boss”: Essential Skills to Succeed as a…
FDA Compliance And Laboratory Computer System Validation
2-Hour Virtual Seminar on the 6 Most Common Problems in FDA…
Managing Toxic & Other Employees Who Have Attitude Issues
Harassment, Bullying, Gossip, Confrontational and Disruptiv…
Managing Complex Projects - Project Management
Tips and Techniques for Conducting an Effective Fraud Risk …
Design Verification, Validation and Testing for Medical Dev…
21 CFR Part 820 - Quality System Regulation - Applying Prin…
Performance Management: Dealing With The Difficult Employee
Treasury Risk Management, Funding, Liquidity, Interest Rate…
OSHA Requirements for Supervisors, Project Leaders & HR - W…
Future-Proof Your Workforce: Mastering Succession Planning …
California Meal and Rest Breaks: What You Don't Know Can Co…
HIPAA Bootcamp for Health Care Providers, Professionals, an…
Essential Job Functions According to the American with Disa…
Improving Employee Engagement & Retention Through Stay Inte…
FFIEC BSA/AML Examination Manual: What Compliance Officers …
Dealing With Difficult People In Life & Work
Introduction to Generative AI for Accountants
Conquer Toxic People - Learn To Protect Yourself And Get Yo…
Updated Metro 2®, e-OSCAR and the New Tougher FCRA/CFPB Com…
3-Hour Virtual Seminar on Excel Deep Dive: Advanced Tips & …
Impact Assessment and Risk Management for Change Control
How to Write Effective Audit Observations: The Principles f…
Surviving and Thriving Organizational Change and Loss: The …
Marijuana: Compliance and Safety in the Workplace
Coming Soon - New Minimum Salary Levels for Exempt Employee…
FDA Regulation of Artificial Intelligence/ Machine Learning
Stressed Out: How to Handle Conflict, Difficult People and …
Data Integrity: Compliance with 21 CFR Part 11, SaaS-Cloud,…
2025 Top Employment Regulations That Will Impact Employers!
How to Handle Workplace Conversations Around Politics and R…
Why EBITDA Doesn't Spell Cash Flow and What Does
How to Give Corrective Feedback: The CARE Model - Eliminati…
SOPs - How to Write Them to Satisfy those Inspectors
Documenting Misconduct that Will Stand Up in Court
With Mandatory Paid Leave Gaining Ground Is It Time To Do A…
Marketing to Medicare or Medicaid Beneficiaries - What You …
Trial Master File (TMF)/eTMF, & FDAs Draft Guidance for Ele…
Project Management for Non-Project Managers - How to commun…
Tattoos, hijabs, piercings, and pink hair: The challenges …
Human Error Reduction Techniques for Floor Supervisors
Onboarding is NOT Orientation - How to Improve the New Empl…
Building GMP Excellence: A Guide to Implementing Compliant …